Global Humira Market Growth 2025-2031

Global Humira Market Growth 2025-2031

The global Humira market size is predicted to grow from US$ 14060 million in 2025 to US$ 8192 million in 2031; it is expected to grow at a CAGR of -8.6% from 2025 to 2031.

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.

Humira is also used in adults and children to treat Crohn"s disease or juvenile idiopathic arthritis.

In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira"s U.S. patent expired in 2016.

The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.

Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.

USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.

Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.

LP Information, Inc. (LPI) ' newest research report, the “Humira Industry Forecast” looks at past sales and reviews total world Humira sales in 2024, providing a comprehensive analysis by region and market sector of projected Humira sales for 2025 through 2031. With Humira sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Humira industry.

This Insight Report provides a comprehensive analysis of the global Humira landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Humira portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Humira market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Humira and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Humira.

This report presents a comprehensive overview, market shares, and growth opportunities of Humira market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Humira Syringe
Humira Pen

Segmentation by Application:
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim

Key Questions Addressed in this Report

What is the 10-year outlook for the global Humira market?

What factors are driving Humira market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Humira market opportunities vary by end market size?

How does Humira break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.